UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Use of Open Access Platforms for Clinical Trial Data

JAMA : the journal of the American Medical Association, 2016-03, Vol.315 (12), p.1283

2016

Volltextzugriff (PDF)

Caution About Overinterpretation of Symptom Indexes in Reflux Monitoring for Refractory Gastroesophageal Reflux Disease

Clinical gastroenterology and hepatology, 2011-10, Vol.9 (10), p.868-874

2011

Volltextzugriff (PDF)

Difference in Medication Adherence Between Patients Prescribed a 30-Day Versus 90-Day Supply After Acute Myocardial Infarction

Journal of the American Heart Association, 2021-01, Vol.10 (1), p.e016215-e016215

2021

Volltextzugriff (PDF)

Differences in Preferences Between Clinicians and Patients for the Use and Dosing of Direct Oral Anticoagulants for Atrial Fibrillation

Journal of the American Heart Association, 2021-06, Vol.10 (11), p.e020697-e020697

2021

Volltextzugriff (PDF)

Challenge in Predicting Persistence to P2Y12 Inhibitors: A Perspective From the ARTEMIS Trial

Journal of the American Heart Association, 2023-06, Vol.12 (12), p.e029063-e029063

2023

Volltextzugriff (PDF)

Accuracy and validation of an automated electronic algorithm to identify patients with atrial fibrillation at risk for stroke

The American heart journal, 2015-01, Vol.169 (1), p.39-44.e2

2015

Volltextzugriff (PDF)

Readmissions After Acute Myocardial Infarction: How Often Do Patients Return to the Discharging Hospital?

Journal of the American Heart Association, 2019-10, Vol.8 (19), p.e012059-e012059

2019

Volltextzugriff (PDF)

Use of Low-Density Lipoprotein-Lowering Therapies Before and After PCSK9 Inhibitor Initiation

Journal of the American Heart Association, 2020-05, Vol.9 (9), p.e014347

2020

Volltextzugriff (PDF)

Does the Effectiveness of a Medicine Copay Voucher Vary by Baseline Medication Out‐Of‐Pocket Expenses? Insights From ARTEMIS

Journal of the American Heart Association, 2022-10, Vol.11 (20), p.e026421-e026421

2022

Volltextzugriff (PDF)

Safety of Dual-Antiplatelet Therapy After Myocardial Infarction Among Patients With Chronic Kidney Disease

Journal of the American Heart Association, 2019-05, Vol.8 (10), p.e012236

2019

Volltextzugriff (PDF)

Cangrelor Use Patterns and Transition to Oral P2Y12 Inhibitors Among Patients With Myocardial Infarction: Initial Results From the CAMEO Registry

Journal of the American Heart Association, 2022-06, Vol.11 (11), p.e024513-e024513

2022

Volltextzugriff (PDF)

Association of Health Status Scores With Cardiovascular and Limb Outcomes in Patients With Symptomatic Peripheral Artery Disease: Insights From the EUCLID (Examining Use of Ticagrelor in Symptomatic Peripheral Artery Disease) Trial

Journal of the American Heart Association, 2020-10, Vol.9 (19), p.e016573-e016573

2020

Volltextzugriff (PDF)

Health-Related Quality of Life Instruments in Chronic Limb-Threatening Ischemia: Evolution of Defining Quality of Life in a Complex Disease State

Circulation (New York, N.Y.), 2024-04, Vol.149 (16), p.1254-1257

2024

Volltextzugriff (PDF)

Advanced Practice Provider Versus Physician-Only Outpatient Follow-Up After Acute Myocardial Infarction

Journal of the American Heart Association, 2018-09, Vol.7 (17), p.e008481-e008481

2018

Volltextzugriff (PDF)

Apixaban for Patients With Atrial Fibrillation on Hemodialysis: A Multicenter Randomized Controlled Trial

Circulation (New York, N.Y.), 2022-12, Vol.146 (23), p.1735-1745

2022

Volltextzugriff (PDF)

Does This Patient With Chest Pain Have Acute Coronary Syndrome?: The Rational Clinical Examination Systematic Review

JAMA : the journal of the American Medical Association, 2015-11, Vol.314 (18), p.1955

2015

Volltextzugriff (PDF)

Drug-Coated Balloons With or Without Provisional Bare Metal Stenting in Femoropopliteal Disease: No Metal Left Behind?

Circulation. Cardiovascular interventions, 2024-02, Vol.17 (2)

2024

Volltextzugriff (PDF)

Managing patients with ST-elevation myocardial infarction and multivessel disease: is the story complete?

European heart journal, 2020-11, Vol.41 (42), p.4111-4113

2020

Volltextzugriff (PDF)

Use of Intravascular Ultrasound to Optimize Peripheral Vascular Interventions: How Do We Optimize Outcomes and Improve Uptake?

Circulation. Cardiovascular interventions, 2023-04, Vol.16 (4), p.e013016

2023

Volltextzugriff (PDF)

The Heterogeneity of Old Age: Healthy Aging in Older Adults Undergoing TAVR

JACC. Cardiovascular interventions, 2023-01, Vol.16 (2), p.189-192

2023

Volltextzugriff (PDF)

Reply: Early-Career Interventionalists: Hope for the Future and Opportunity for Change

Journal of the American College of Cardiology, 2024-10, Vol.84 (15), p.e241-e241

2024

Volltextzugriff (PDF)

Challenges in Peripheral Artery Disease Clinical Trial Implementation and Design

Canadian journal of cardiology, 2022-05, Vol.38 (5), p.699-702

2022

Volltextzugriff (PDF)

High economic burden of caring for patients with suspected extraesophageal reflux

The American journal of gastroenterology, 2013-06, Vol.108 (6), p.905-911

2013

Volltextzugriff (PDF)

Anemia and coronary artery disease: pathophysiology, prognosis, and treatment

Coronary artery disease, 2018-03, Vol.29 (2), p.161-167

2018

Volltextzugriff (PDF)

Implications of a Race Term in GFR Estimates Used to Predict AKI After Coronary Intervention

JACC. Cardiovascular interventions, 2023-09, Vol.16 (18), p.2309-2320

2023

Volltextzugriff (PDF)

1 – 25 von 215

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(209)
Mit Volltextzugriff
(190)

Publikationsform

Sprache

Englisch
(215)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(8)
... seit 90 Tagen
(11)

Menü

Weitere Dienste

Einstellungen

Use of Open Access Platforms for Clinical Trial Data

Caution About Overinterpretation of Symptom Indexes in Reflux Monitoring for Refractory Gastroesophageal Reflux Disease

Difference in Medication Adherence Between Patients Prescribed a 30-Day Versus 90-Day Supply After Acute Myocardial Infarction

Differences in Preferences Between Clinicians and Patients for the Use and Dosing of Direct Oral Anticoagulants for Atrial Fibrillation

Challenge in Predicting Persistence to P2Y12 Inhibitors: A Perspective From the ARTEMIS Trial

Accuracy and validation of an automated electronic algorithm to identify patients with atrial fibrillation at risk for stroke

Readmissions After Acute Myocardial Infarction: How Often Do Patients Return to the Discharging Hospital?

Use of Low-Density Lipoprotein-Lowering Therapies Before and After PCSK9 Inhibitor Initiation

Does the Effectiveness of a Medicine Copay Voucher Vary by Baseline Medication Out‐Of‐Pocket Expenses? Insights From ARTEMIS

Safety of Dual-Antiplatelet Therapy After Myocardial Infarction Among Patients With Chronic Kidney Disease

Cangrelor Use Patterns and Transition to Oral P2Y12 Inhibitors Among Patients With Myocardial Infarction: Initial Results From the CAMEO Registry

Association of Health Status Scores With Cardiovascular and Limb Outcomes in Patients With Symptomatic Peripheral Artery Disease: Insights From the EUCLID (Examining Use of Ticagrelor in Symptomatic Peripheral Artery Disease) Trial

Health-Related Quality of Life Instruments in Chronic Limb-Threatening Ischemia: Evolution of Defining Quality of Life in a Complex Disease State

Advanced Practice Provider Versus Physician-Only Outpatient Follow-Up After Acute Myocardial Infarction

Apixaban for Patients With Atrial Fibrillation on Hemodialysis: A Multicenter Randomized Controlled Trial

Does This Patient With Chest Pain Have Acute Coronary Syndrome?: The Rational Clinical Examination Systematic Review

Drug-Coated Balloons With or Without Provisional Bare Metal Stenting in Femoropopliteal Disease: No Metal Left Behind?

Managing patients with ST-elevation myocardial infarction and multivessel disease: is the story complete?

Use of Intravascular Ultrasound to Optimize Peripheral Vascular Interventions: How Do We Optimize Outcomes and Improve Uptake?

The Heterogeneity of Old Age: Healthy Aging in Older Adults Undergoing TAVR

Reply: Early-Career Interventionalists: Hope for the Future and Opportunity for Change

Challenges in Peripheral Artery Disease Clinical Trial Implementation and Design

High economic burden of caring for patients with suspected extraesophageal reflux

Anemia and coronary artery disease: pathophysiology, prognosis, and treatment

Implications of a Race Term in GFR Estimates Used to Predict AKI After Coronary Intervention

Suchergebnisse filtern